Investigational combination of first-in-class bispecifics TALVEY\u00ae and TECVAYLI\u00ae shows deep and durable responses in he

Posted June 15, 2025 by Two Blokes

Results from the Phase 2 RedirecTT-1 study demonstrate deep responses with 78.9 percent overall response rate

Source: Two Blokes Trading

QIAGEN and Incyte Announce Precision Medicine Collaboration to Develop Companion Diagnostics for Patients With Mutant CALR-expre

Posted June 15, 2025 by Two Blokes

VENLO, Netherlands & WILMINGTON, Del.--(BUSINESS WIRE)---- $QGEN #QIAGEN--QIAGEN N.V. (NYSE: QGEN; Frankfurt P

Source: Two Blokes Trading

Statistically and Historically Speaking, 2 of Wall Street's Highest-Flying Stocks Are in Epic Bubbles That I Fully Expect to Bur

Posted June 15, 2025 by Two Blokes

For well over a century, Wall Street has been a stomping ground for wealth creation. Although getting from Poi

Source: Two Blokes Trading

Positive Late-Breaking Data for Incyte's First-in-Class mutCALR-targeted therapy INCA033989 in Essential Thrombocythemia Present

Posted June 15, 2025 by Two Blokes

WILMINGTON, Del.--(BUSINESS WIRE)---- $INCY--Positive Late-Breaking Data for Incyte's First-in-Class mutCALR-t

Source: Two Blokes Trading

Genmab Announces Epcoritamab Investigational Combination Therapy Demonstrates High Response Rates in Patients with Relapsed or R

Posted June 15, 2025 by Two Blokes

Media Release COPENHAGEN, Denmark; June 15, 2025 Results from the EPCORE \u00ae NHL-2 trial show investigation

Source: Two Blokes Trading

Investigational combination of first-in-class bispecifics TALVEY\u00ae and TECVAYLI\u00ae shows deep and durable responses in he

Posted June 15, 2025 by Two Blokes

Results from the Phase 2 RedirecTT-1 study demonstrate deep responses with 78.9 percent overall response rate

Source: Two Blokes Trading

QIAGEN and Incyte Announce Precision Medicine Collaboration to Develop Companion Diagnostics for Patients With Mutant CALR-expre

Posted June 15, 2025 by Two Blokes

VENLO, Netherlands & WILMINGTON, Del.--(BUSINESS WIRE)---- $QGEN #QIAGEN--QIAGEN N.V. (NYSE: QGEN; Frankfurt P

Source: Two Blokes Trading

Genmab Announces Epcoritamab Investigational Combination Therapy Demonstrates High Response Rates in Patients with Relapsed or R

Posted June 15, 2025 by Two Blokes

Media Release COPENHAGEN, Denmark; June 15, 2025 Results from the EPCORE \u00ae NHL-2 trial show investigation

Source: Two Blokes Trading

ZBIO DEADLINE ALERT: ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Zenas BioPharma, Inc. Investors with Losses in Excess of $

Posted June 15, 2025 by Two Blokes

NEW YORK CITY, NY / ACCESS Newswire / June 14, 2025 / WHY: New York, N.Y., June 14, 2025.

Source: Two Blokes Trading

IBTA DEADLINE ALERT: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Ibotta, Inc. Investors with Losses in Excess of $100K to Sec

Posted June 15, 2025 by Two Blokes

NEW YORK CITY, NY / ACCESS Newswire / June 14, 2025 / WHY: New York, N.Y., June 14, 2025.

Source: Two Blokes Trading

ZBIO DEADLINE ALERT: ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Zenas BioPharma, Inc. Investors with Losses in Excess of $

Posted June 15, 2025 by Two Blokes

NEW YORK CITY, NY / ACCESS Newswire / June 14, 2025 / WHY: New York, N.Y., June 14, 2025.

Source: Two Blokes Trading

Class Action Lawsuit Alert: Levi & Korsinsky Reminds Compass Group Diversified Holdings, LLC (CODI) Investors of July 8, 2025 De

Posted June 15, 2025 by Two Blokes

NEW YORK, NY / ACCESS Newswire / June 14, 2025 / If you suffered a loss on your Compass Group Diversified Hold

Source: Two Blokes Trading